NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/06/2025
Back to search
Official data from USPTO
ARTHROSAMID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARTHROSAMID
ST13
US500000079085553Class
5, 10
Filing
79085553
Registration
3995874
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
01/07/2025
Trademark type
Word
Nice classes
5, 10
Filing date
03/03/2010
Registration date
07/19/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/23/2018
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DK
Examiner
MADDEN, ANNE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Contura A/S
Representatives
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett &
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Injectable surgical gels for medical use for the alleviation of arthritis symptoms and for treatment of arthritis and degenerative joint diseases; injectable gels for the treatment of arthritis; medical and surgical gels for surgical use for the alleviation of arthritis symptoms and for treatment of arthritis and degenerative joint diseases; injectable gels for surgical use for the alleviation of arthritis symptoms and for treatment of arthritis and degenerative joint diseases
Class 10
Medical and surgicalimplants made of artificial materials; injectable implants made of artificial materials for surgical use; injectable implants made of artificial materials for the treatment of arthritis
Publications
History of USPTO decisions and trademark events.
36 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/26/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/09/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/04/2019
GPNX
NOTIFICATION PROCESSED BY IB
03/08/2019
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
12/14/2018
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
11/05/2018
INPC
INVALIDATION PROCESSED
11/05/2018
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/23/2018
RFNT
REFUSAL PROCESSED BY IB
08/10/2018
C71T
CANCELLED SECTION 71
02/23/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/21/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/11/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/24/2012
FIMP
FINAL DISPOSITION PROCESSED
01/24/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/19/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
07/19/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2011
PUBO
PUBLISHED FOR OPPOSITION
05/03/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/13/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/13/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/25/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2011
ALIE
ASSIGNED TO LIE
03/16/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2011
RFNT
REFUSAL PROCESSED BY IB
10/03/2010
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/07/2010
RFRR
REFUSAL PROCESSED BY MPU
09/07/2010
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/05/2010
CNRT
NON-FINAL ACTION WRITTEN
09/04/2010
MAFR
APPLICATION FILING RECEIPT MAILED
08/31/2010
DOCK
ASSIGNED TO EXAMINER
08/27/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2010
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/26/2010
Continuous trademark protection
Get notified about every new filing that threatens ARTHROSAMID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.